Drug intelligence / Profile preview

codeine + magnesium oxide

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

**Codeine + magnesium oxide** is a fixed-dose combination of the opioid analgesic and antitussive codeine with the antacid and laxative magnesium oxide. Codeine acts primarily as an agonist at **mu-opioid receptors** in the central nervous system, suppressing cough reflex via the medullary cough center and providing mild analgesia, while also reducing intestinal motility that can lead to constipation; it is partially metabolized to morphine via CYP2D6 for enhanced activity. Magnesium oxide neutralizes gastric acid as an antacid and serves as an osmotic laxative to relieve constipation and indigestion. This combination may be used for pain relief with concurrent gastrointestinal symptom management, though pharmacokinetic interactions exist where magnesium oxide can reduce codeine absorption, and it carries risks of opioid dependence, respiratory depression, and constipation.[2][3][8]

02

Targets

MOR (Mu opioid receptor)KOR (Kappa opioid receptor)DOR (Opioid Receptor Delta 1)

Beyond the preview

Go deeper on codeine + magnesium oxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on codeine + magnesium oxide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call